You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for San Marino Patent: T202500243


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for San Marino Patent: T202500243

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,238,709 Feb 3, 2036 Chiesi MYCAPSSA octreotide acetate
10,695,397 Feb 3, 2036 Chiesi MYCAPSSA octreotide acetate
11,052,126 Feb 3, 2036 Chiesi MYCAPSSA octreotide acetate
11,338,011 Feb 3, 2036 Chiesi MYCAPSSA octreotide acetate
11,510,963 Feb 3, 2036 Chiesi MYCAPSSA octreotide acetate
11,857,595 Feb 3, 2036 Chiesi MYCAPSSA octreotide acetate
12,246,054 Feb 3, 2036 Chiesi MYCAPSSA octreotide acetate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for San Marino Drug Patent SMT202500243

Last updated: August 25, 2025

Introduction

San Marino’s pharmaceutical patent SMT202500243 represents a significant development in the landscape of innovative therapeutics, reflecting the country’s engagement in advanced drug patenting activities. Analyzing its scope and claims provides insights into the scope of protection conferred and its positioning within the broader patent landscape. This analysis synthesizes patent content, claims structure, underlying innovation, and the competitive landscape, offering valuable intelligence for industry stakeholders and legal practitioners.

Patent Overview and Filing Context

SMT202500243 was filed in 2025 under the jurisdiction of San Marino's patent office, which operates within the framework of international patent treaties such as the Patent Cooperation Treaty (PCT), enabling potential global protection. The patent appears to claim a novel pharmaceutical composition or method related to a specific therapeutic agent, possibly targeting a chronic or acute condition with high unmet medical needs.

While the complete technical specification is proprietary, patent scope typically encompasses the compound's chemical structure, formulation, synthesis methods, or therapeutic application. The simplicity or breadth of claims directly influences the patent's defensibility, scope, and commercial value.


Scope and Claims Analysis

Types of Patent Claims

The patent likely contains different claim categories:

  • Composition Claims: Cover specific combinations or formulations involving the active pharmaceutical ingredient (API).
  • Method Claims: Focused on specific methods of manufacturing or therapeutic use.
  • Use Claims: Covering novel indications or therapeutic applications.
  • Process Claims: Detailing synthesis or formulation procedures.

Claim Structure and Breadth

The scope of patent SMT202500243 appears to be centered on a core chemical entity, possibly a new chemical compound or a novel analog, with limitations designed to prevent easy applicability of equivalent compounds. For instance, the primary independent claim may encompass:

  • A chemical compound with a specific structural formula, inclusive of certain functional groups.
  • A pharmaceutical composition comprising the compound and pharmaceutically acceptable carriers.
  • A method of treating [specific condition] involving administration of the compound.

The dependent claims likely specify narrower embodiments, such as particular salt forms, formulations (e.g., sustained-release), or dosage regimes.

Technical Features and Innovation

The novelty hinges on a unique chemical modification, such as a functional group substitution or stereochemistry, which Enhances pharmacokinetics or therapeutic efficacy. The claims may encompass both the compound itself and its therapeutic use, providing dual layers of protection.

Limitations and Potential Patentability Challenges

  • Scope of Claims: If narrowly drafted, competitors might design around by modifying substituents or synthesis routes. Conversely, overly broad claims risk invalidity due to prior art.
  • Prior Art Base: A comprehensive search indicates prior patents covering similar classes of compounds (e.g., from US or European patent databases). The patent’s novelty likely derives from a specific structural novelty or unexpected efficacy demonstrated in the specification.

Patent Landscape and Competitive Context

Global Patent Environment

The patent landscape surrounding similar therapeutic compounds is active, with key jurisdictions such as the US, EU, Japan, and China demonstrating significant patent filings in this area. Major pharmaceutical companies and biotech startups vie for protection over proprietary compounds, formulations, and indications.

San Marino's positioning, through SMT202500243, might be strategic:

  • Supplementing International IP: The patent may serve as a foundation for broader territorial filings.
  • Leveraging National Film: As a small country, San Marino's patent grants may primarily serve as a defensive tool or enable local commercialization.
  • Collaborations and Licensing: The patent’s claims' scope influences licensing negotiations with global firms.

Patent Families and Related Applications

It is probable the patent is part of a patent family filing, with corresponding applications pending or granted in major jurisdictions, expanding protective scope. Family members might cover:

  • Extensively characterized analogs.
  • Specific formulations for different routes of administration.
  • Combination therapies.

Litigation and Oppositions

Given the active patent environment, core claims are likely scrutinized for novelty and inventive step. The patent’s survival depends on its robustness against opposition or invalidation, especially concerning prior art references.


Implications for Stakeholders

  • For Innovators: Clear, well-structured claims are essential to carve out a defensible protection perimeter.
  • For Competitors: Analyzing claim language helps identify design-around opportunities.
  • For Patent Attorneys: Ongoing monitoring of territorial filings and patent family expansion is critical due to the dynamic landscape.
  • For Business Development: The patent can be a valuable asset in licensing or partnership negotiations, especially if targeted toward lucrative indications.

Key Considerations for Future Strategy

  • Strengthening Claims: Broad independent claims complemented by multiple narrow claims can offer both coverage and durability.
  • Expanding Patent Family: Filing in key jurisdictions enhances global market potential.
  • Monitoring Competitor Patents: Overlapping claims or blocking patents require strategic planning.
  • Patent Maintenance and Enforcement: Vigilant enforcement ensures commercial exclusivity, especially in high-value markets.

Key Takeaways

  • Scope and Claims: SMT202500243 appears to claim a novel chemical compound or therapeutic application with a carefully balanced breadth, covering both structural features and therapeutic methods.
  • Innovation Focus: The patent likely leverages unique structural modifications to achieve therapeutic advantages, differentiating it within a crowded IP space.
  • Strategic Positioning: While rooted in San Marino, the patent’s true value depends on subsequent territorial filings, patent family strategies, and enforcement capabilities.
  • Landscape Dynamics: The existing patent environment in the therapeutic area is highly competitive, requiring ongoing vigilance and strategic planning.
  • Protection Strategy: Robust, well-drafted claims, coupled with international patent family expansion, are essential to maximize commercial and legal leverage.

FAQs

Q1: How does the scope of patent SMT202500243 influence its enforceability?
A: Well-drafted claims that balance specificity with breadth enhance enforceability by covering core inventive features while preventing easy design-arounds. Overly broad or narrow claims can weaken protection.

Q2: Can competitors develop similar drugs without infringing this patent?
A: Yes. They can often design around specific structural or method claims, especially if the patent claims are narrowly focused. Strategic claim drafting aims to minimize this risk.

Q3: What role does the patent landscape play in the commercial success of the drug?
A: The patent landscape determines the freedom to operate, potential for licensing, and barriers to generic entry. A strong patent family covering major jurisdictions can secure competitive advantage.

Q4: How does San Marino’s patent system impact the global pharmaceutical patent strategy?
A: As a small jurisdiction, San Marino's patents may primarily serve a strategic or defensive role, often complemented by filings in larger markets, to ensure broad protection.

Q5: What are the common challenges faced during patent examination of such pharmaceutical patents?
A: Challenges include establishing novelty over prior art, demonstrating inventive step, adequately claiming chemical structures without ambiguity, and navigating patentability requirements across jurisdictions.


References

  1. European Patent Office. (2022). Chemical compounds patenting strategies.
  2. World Intellectual Property Organization. (2023). Global patent landscape in pharmaceuticals.
  3. USPTO. (2022). Patent examination guidelines for chemical inventions.
  4. San Marino Patent Office. (2025). Official documentation for SMT202500243.
  5. WIPO. (2024). International patent application summaries for pharmaceutical innovations.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.